.avif)
LDH Test - Testicular Cancer Biomarker
An LDH (lactate dehydrogenase) test measures enzyme levels to detect tissue damage and cellular stress—helping identify early signs of heart attack, liver disease, hemolytic anemia, muscle injury, and some cancers. Catching abnormalities sooner lets you get prompt treatment and avoid more serious complications.
Beta-hCG Test - Testicular Cancer Biomarker
Detects and measures pregnancy hormone (beta‑hCG) to confirm early pregnancy and monitor its progress quickly and accurately. Early detection and trending can reveal non‑viable pregnancies, ectopic or molar pregnancies, and abnormal developments so you can seek timely medical care.
AFP Test - Testicular Cancer Biomarker
The AFP (alpha‑fetoprotein) test measures protein levels in maternal or patient blood to screen pregnancies for neural tube and abdominal wall defects and to help detect or monitor liver cancer and certain germ‑cell tumors. Early detection prompts follow‑up care and treatment, reducing risk of complications and improving outcomes.
Beta-hCG Test - Testicular Cancer Biomarker
A Beta-hCG test detects and measures pregnancy hormone levels to confirm pregnancy and monitor its early progress. Early results can help identify risks such as ectopic pregnancy, miscarriage, or trophoblastic disease so you can get prompt care and reduce the chance of serious complications.
AFP Test - Testicular Cancer Biomarker
This AFP (alpha‑fetoprotein) test screens in pregnancy for neural tube defects and certain chromosomal conditions and serves in adults as a marker to detect or monitor liver and germ‑cell cancers. Early detection enables timely follow‑up and treatment, helping reduce the risk of serious complications.
.svg)
